Addison K. May
Research Subjects
Addison K. May has a total of 505 co-authors. Here are the top co-authors by number of shared publications:
- Lorraine B. Ware
Vanderbilt University Medical Center
8 shared publications - Robert G. Sawyer
Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, Michigan, USA
8 shared publications - Lesly A. Dossett
University of Michigan, Department of Surgery, Ann Arbor, MI, USA
7 shared publications - Ari Leppäniemi
The University of Helsinki, Helsinki, Finland
6 shared publications - Ernest Eugene Moore
Ernest E. Moore Shock Trauma Center, Denver Health, Denver, CO 80204, USA
6 shared publications - Federico Coccolini
Department of General, Emergency and Trauma Surgery, Pisa University Hospital, Pisa, Italy
6 shared publications
Latest Publications
- 15 October 2026
- Published by Taylor & Francis in Traffic Injury Prevention
- p. 1-10
Bone microarchitecture, density, and strength assessment in automotive trauma patients using HR-pQCT: a pilot study
Automotive trauma in motor vehicle crash (MVC) occupants and pedestrians is a leading cause of injuries and death amongst children and adults in the United States (NHTSA 2024, 2025). Many of these ...
- 15 October 2026
- Published by Taylor & Francis in Traffic Injury Prevention
- p. 1-10
Bone microarchitecture, density, and strength assessment in automotive trauma patients using HR-pQCT: a pilot study
Automotive trauma in motor vehicle crash (MVC) occupants and pedestrians is a leading cause of injuries and death amongst children and adults in the United States (NHTSA 2024, 2025). Many of these ...
- 11 June 2026
- Published by Taylor & Francis in Traffic Injury Prevention
- Vol. 27 (sup1) , 1-11
Validation and application of automated CT analysis to musculoskeletal profiling in MVC occupants
Motor vehicle collisions (MVCs) are a leading cause of fracture-related morbidity and healthcare cost in the United States (Peterson et al. 2021; Yuan et al. 2023). However, fracture risk following...
- 11 June 2026
- Published by Taylor & Francis in Traffic Injury Prevention
- Vol. 27 (sup1) , 1-11
Validation and application of automated CT analysis to musculoskeletal profiling in MVC occupants
Motor vehicle collisions (MVCs) are a leading cause of fracture-related morbidity and healthcare cost in the United States (Peterson et al. 2021; Yuan et al. 2023). However, fracture risk following...
- 14 October 2024
- Published by Springer Nature in Surgical Endoscopy
- Vol. 39 (1) , 472-479
Rise of the robots: implementing robotic surgery into the acute care surgery practice
Objectives Acute Care Surgery (ACS) admissions and procedures are substantially increasing. ACS disproportionally accounts for a majority of morbidity and mortality among surgical patients. Minimally invasive techniques are associated with improved outcomes and shorter hospital length of stay within the ACS population. While laparoscopy is widespread, ACS surgeons have been slower to adopt the use of robotics. We aimed to evaluate the feasibility of incorporating robotic surgery within ACS practice. Methods Robotic General Surgery operations performed by 8 Acute Care Surgeons from 5 local facilities within a large integrated healthcare system were queried over a 15 month period. Patients who underwent emergent, urgent, sub-acute, and elective robotic operations by ACS staff were identified. Demographics collected included age, gender, BMI, and ASA score. Outcomes recorded included procedure classification, total supply and implant charges (TSI), conversion to open, hospital length of stay (LOS), 30 day readmission, and 30 day mortality. Results Of 200 operations, the most common were Cholecystectomy (43.5%), Inguinal hernia repair (26.0%), Ventral hernia repair (18.0%), Appendectomy (5.0%), and Sigmoid Colectomy (3.5%). The median (± std dev) age was 48 ± 16.66 years and BMI was 29.9 ± 8.79 kg/m2. 46% of cases were sub-acute (n = 92), 33.5% were elective (n = 67), 14% were emergent (n = 28), and 6.5% were urgent (n = 13). Most patients were ASA 2 (107, 46.1%) or ASA 3 (71, 45.9%). The median (IQR) TSI and LOS were $1,770 (889.50) USD and 0.1 (0.9) days. Forty-one inpatient procedures were performed. Median LOS was 3 days and expected LOS was 3.1 days (O:E = 0.96). Five patients were readmitted within 30 days, and there were no deaths within 30 days. Conclusion Robotic techniques may be safely implemented by ACS surgeons, potentially benefitting both patient and surgeon. LOS was similar between laparoscopic and robotic cases and only two cases required conversion to an open procedure. Next steps include a multi-center prospective trial comparing robotic to laparoscopic cases.
- 14 October 2024
- Published by Springer Nature in Surgical Endoscopy
- Vol. 39 (1) , 472-479
Rise of the robots: implementing robotic surgery into the acute care surgery practice
Objectives Acute Care Surgery (ACS) admissions and procedures are substantially increasing. ACS disproportionally accounts for a majority of morbidity and mortality among surgical patients. Minimally invasive techniques are associated with improved outcomes and shorter hospital length of stay within the ACS population. While laparoscopy is widespread, ACS surgeons have been slower to adopt the use of robotics. We aimed to evaluate the feasibility of incorporating robotic surgery within ACS practice. Methods Robotic General Surgery operations performed by 8 Acute Care Surgeons from 5 local facilities within a large integrated healthcare system were queried over a 15 month period. Patients who underwent emergent, urgent, sub-acute, and elective robotic operations by ACS staff were identified. Demographics collected included age, gender, BMI, and ASA score. Outcomes recorded included procedure classification, total supply and implant charges (TSI), conversion to open, hospital length of stay (LOS), 30 day readmission, and 30 day mortality. Results Of 200 operations, the most common were Cholecystectomy (43.5%), Inguinal hernia repair (26.0%), Ventral hernia repair (18.0%), Appendectomy (5.0%), and Sigmoid Colectomy (3.5%). The median (± std dev) age was 48 ± 16.66 years and BMI was 29.9 ± 8.79 kg/m2. 46% of cases were sub-acute (n = 92), 33.5% were elective (n = 67), 14% were emergent (n = 28), and 6.5% were urgent (n = 13). Most patients were ASA 2 (107, 46.1%) or ASA 3 (71, 45.9%). The median (IQR) TSI and LOS were $1,770 (889.50) USD and 0.1 (0.9) days. Forty-one inpatient procedures were performed. Median LOS was 3 days and expected LOS was 3.1 days (O:E = 0.96). Five patients were readmitted within 30 days, and there were no deaths within 30 days. Conclusion Robotic techniques may be safely implemented by ACS surgeons, potentially benefitting both patient and surgeon. LOS was similar between laparoscopic and robotic cases and only two cases required conversion to an open procedure. Next steps include a multi-center prospective trial comparing robotic to laparoscopic cases.
- 1 April 2023
- Published by SAGE Publications in Surgical Infections
- Vol. 24 (3) , 276-283
Host Microbiome Threats in the Intensive Care Unit
Human microbiota demonstrate diversity and balance that is adaptive for the host and supports maintaining homeostasis. Although acute illness or injury may derange microbiota diversity and the proportion of potentially pathogenic microbes, that derangement may be further exacerbated by commonly deployed intensive care unit (ICU) therapeutic and practices. These include antibiotic administration, delayed luminal nutrition, acid suppression, and vasopressor infusion. Furthermore, the local ICU microbial ecology, regardless of disinfection practices, shapes the patient's microbiota, especially with the acquisition of multi-drug–resistant pathogens. Current approaches to protect a normal microbiome, or restore a deranged one, are part of a multifaceted approach that may include antibiotic stewardship and infection control practices as microbiome-directed therapeutics emerge.
- 1 April 2023
- Published by SAGE Publications in Surgical Infections
- Vol. 24 (3) , 276-283
Host Microbiome Threats in the Intensive Care Unit
Human microbiota demonstrate diversity and balance that is adaptive for the host and supports maintaining homeostasis. Although acute illness or injury may derange microbiota diversity and the proportion of potentially pathogenic microbes, that derangement may be further exacerbated by commonly deployed intensive care unit (ICU) therapeutic and practices. These include antibiotic administration, delayed luminal nutrition, acid suppression, and vasopressor infusion. Furthermore, the local ICU microbial ecology, regardless of disinfection practices, shapes the patient's microbiota, especially with the acquisition of multi-drug–resistant pathogens. Current approaches to protect a normal microbiome, or restore a deranged one, are part of a multifaceted approach that may include antibiotic stewardship and infection control practices as microbiome-directed therapeutics emerge.
- 17 October 2022
- Published by Elsevier in The American Journal of Surgery
- Vol. 224 (6) , 1409-1416
Emergencies do not shut down during a pandemic: COVID pandemic impact on Acute Care Surgery volume and mortality at a level I trauma center
- 17 October 2022
- Published by Elsevier in The American Journal of Surgery
- Vol. 224 (6) , 1409-1416
Emergencies do not shut down during a pandemic: COVID pandemic impact on Acute Care Surgery volume and mortality at a level I trauma center
- 16 September 2022
- Published by Springer Nature
- p. 293-304
Necrotizing Soft Tissue Infections
- 23 August 2022
- Published by Springer Nature
- p. 211-220
Principles of ICU Resuscitation and Team-Based Care
- 23 August 2022
- Published by Springer Nature
- p. 211-220
Principles of ICU Resuscitation and Team-Based Care
- 27 September 2021
- Published by Taylor & Francis
- p. 175-179
Treatment of Abdominal Sepsis
Abdominal sepsis is a common clinical condition requiring management in the intensive care unit and may present significant diagnostic and management challenges. The core principles of therapy include appropriate and timely resuscitation, antimicrobial therapy, and source control; each impacting the outcome of critically ill patients with abdominal sepsis. Most intraabdominal infections are due to enteric bacteria. Community acquired secondary peritonitis is typically polymicrobial with facultative and aerobic gram-negative, gram-positive, and anaerobic organisms. Critically ill abdominal sepsis patients with failure of source control present significant diagnostic challenges. Patients with recurrent or persistent peritonitis and with nosocomial infections have an increased prevalence of resistant gram-negative pathogens, Enterococcus spp., methicillin resistant Staphylococcus aureus, and yeast typically requiring three agents to achieve appropriate coverage of pathogens. For critically ill patients, empiric therapy should be directed to include all these pathogens with either single agent or combination therapy.
- 27 September 2021
- Published by Taylor & Francis
- p. 175-179
Treatment of Abdominal Sepsis
Abdominal sepsis is a common clinical condition requiring management in the intensive care unit and may present significant diagnostic and management challenges. The core principles of therapy include appropriate and timely resuscitation, antimicrobial therapy, and source control; each impacting the outcome of critically ill patients with abdominal sepsis. Most intraabdominal infections are due to enteric bacteria. Community acquired secondary peritonitis is typically polymicrobial with facultative and aerobic gram-negative, gram-positive, and anaerobic organisms. Critically ill abdominal sepsis patients with failure of source control present significant diagnostic challenges. Patients with recurrent or persistent peritonitis and with nosocomial infections have an increased prevalence of resistant gram-negative pathogens, Enterococcus spp., methicillin resistant Staphylococcus aureus, and yeast typically requiring three agents to achieve appropriate coverage of pathogens. For critically ill patients, empiric therapy should be directed to include all these pathogens with either single agent or combination therapy.